Jennison Associates’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,469,285
| Closed | -$1.72M | – | 655 |
|
|
2024
Q2 | $1.72M | Sell |
1,469,285
-1,496,598
| -50% | -$1.75M | ﹤0.01% | 454 |
|
|
2024
Q1 | $26.8M | Buy |
2,965,883
+6,722
| +0.2% | +$60.8K | 0.02% | 311 |
|
|
2023
Q4 | $32.2M | Buy |
2,959,161
+3,818
| +0.1% | +$41.5K | 0.02% | 262 |
|
|
2023
Q3 | $23.8M | Buy |
2,955,343
+1,089,913
| +58% | +$8.77M | 0.02% | 288 |
|
|
2023
Q2 | $20.3M | Buy |
+1,865,430
| New | +$20.3M | 0.02% | 316 |
|
|
2019
Q3 | – | Sell |
-1,061,791
| Closed | -$17.6M | – | 698 |
|
|
2019
Q2 | $17.6M | Sell |
1,061,791
-70,040
| -6% | -$1.16M | 0.02% | 372 |
|
|
2019
Q1 | $18.9M | Sell |
1,131,831
-6,859
| -0.6% | -$115K | 0.02% | 360 |
|
|
2018
Q4 | $13.1M | Buy |
1,138,690
+663,059
| +139% | +$7.61M | 0.01% | 408 |
|
|
2018
Q3 | $19M | Sell |
475,631
-213,708
| -31% | -$8.55M | 0.02% | 403 |
|
|
2018
Q2 | $19.5M | Buy |
689,339
+5,433
| +0.8% | +$154K | 0.02% | 407 |
|
|
2018
Q1 | $10.5M | Buy |
683,906
+9,768
| +1% | +$149K | 0.01% | 451 |
|
|
2017
Q4 | $22M | Buy |
674,138
+272,455
| +68% | +$8.89M | 0.02% | 389 |
|
|
2017
Q3 | $9.43M | Buy |
401,683
+198,767
| +98% | +$4.67M | 0.01% | 485 |
|
|
2017
Q2 | $1.11M | Buy |
202,916
+105,400
| +108% | +$578K | ﹤0.01% | 563 |
|
|
2017
Q1 | $690K | Buy |
+97,516
| New | +$690K | ﹤0.01% | 584 |
|